Emily Harris

19.2k total citations · 1 hit paper
183 papers, 2.9k citations indexed

About

Emily Harris is a scholar working on Epidemiology, Hematology and Infectious Diseases. According to data from OpenAlex, Emily Harris has authored 183 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 19 papers in Hematology and 18 papers in Infectious Diseases. Recurrent topics in Emily Harris's work include Iron Metabolism and Disorders (18 papers), Hemoglobinopathies and Related Disorders (15 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Emily Harris is often cited by papers focused on Iron Metabolism and Disorders (18 papers), Hemoglobinopathies and Related Disorders (15 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Emily Harris collaborates with scholars based in United States, Canada and Australia. Emily Harris's co-authors include Paul C. Adams, James C. Barton, Ronald T. Acton, Gordon D. McLaren, David M. Reboussin, Mark Speechley, Fitzroy W. Dawkins, Phyliss Sholinsky, Victor R. Gordeuk and Christine E. McLaren and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Emily Harris

156 papers receiving 2.8k citations

Hit Papers

Hemochromatosis and Iron-Overload Screening in a Racially... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers

Emily Harris
Dan L. Longo United States
John D. Roback United States
Peter Jacobs South Africa
Sharon E. Cox United Kingdom
Alan E. Mast United States
Arjumand S. Warsy Saudi Arabia
James G. Taylor United States
Emily Harris
Citations per year, relative to Emily Harris Emily Harris (= 1×) peers Paolo Pedrazzoli

Countries citing papers authored by Emily Harris

Since Specialization
Citations

This map shows the geographic impact of Emily Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Harris more than expected).

Fields of papers citing papers by Emily Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Harris. The network helps show where Emily Harris may publish in the future.

Co-authorship network of co-authors of Emily Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Harris. A scholar is included among the top collaborators of Emily Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Harris. Emily Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Emily. (2024). Oral Drug as Effective as Topical Cream for Male Pattern Baldness. JAMA. 331(20). 1698–1698. 1 indexed citations
2.
Harris, Emily. (2024). WHO: As Mpox Outbreaks Continue, Cases May Be Underestimated. JAMA. 331(24). 2070–2070. 2 indexed citations
3.
Harris, Emily. (2024). About One-Third of Older Adults Still Use Aspirin for Heart, Despite New Data. JAMA. 332(6). 447–447. 1 indexed citations
4.
Harris, Emily. (2024). CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle. JAMA. 331(19). 1615–1615. 3 indexed citations
5.
Harris, Emily. (2024). FDA Okays First Drug for Scarring From Fatty Liver Disease. JAMA. 331(17). 1439–1439. 3 indexed citations
6.
Harris, Emily. (2024). WHO Launches Broad Coronavirus Surveillance Network. JAMA. 331(19). 1615–1615. 1 indexed citations
7.
Harris, Emily. (2024). Swapping Salt for a Substitute May Lower Deaths, Reduce Heart Problems. JAMA. 331(20). 1698–1698. 1 indexed citations
8.
Harris, Emily. (2024). CDC Warns of Surge in Meningococcal Disease in US. JAMA. 331(19). 1614–1614. 2 indexed citations
9.
Harris, Emily. (2024). New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases. JAMA. 331(10). 821–821. 1 indexed citations
10.
Harris, Emily. (2024). Mixed Results on Whether Interventions Reduce Polypharmacy. JAMA. 331(6). 467–467. 1 indexed citations
11.
Harris, Emily. (2023). Blood Biomarker Helps Distinguish Vascular Dementia. JAMA. 329(12). 969–969. 2 indexed citations
12.
Harris, Emily. (2023). COVID-19 Vaccination During Pregnancy Protected Infants. JAMA. 329(10). 789–789.
13.
Harris, Emily. (2023). Case of Middle East Respiratory Syndrome Coronavirus Confirmed. JAMA. 330(8). 685–685. 1 indexed citations
14.
Harris, Emily. (2023). Risk-Benefit Ratio Might Favor Lower Oral Anticoagulant Doses. JAMA. 330(22). 2145–2145. 1 indexed citations
15.
Harris, Emily. (2023). FDA Approves First Chikungunya Vaccine. JAMA. 330(23). 2241–2241. 3 indexed citations
16.
Harris, Emily. (2023). Sudden Cardiac Deaths Have Decreased Among Young Athletes. JAMA. 330(24). 2331–2331.
17.
Harris, Emily. (2023). Mental Illness Might Be Early Feature of Multiple Sclerosis. JAMA. 330(17). 1612–1612. 1 indexed citations
18.
Harris, Emily. (2023). CDC: Candida auris Fungal Infections and Drug Resistance on the Rise. JAMA. 329(15). 1248–1248. 7 indexed citations
19.
Harris, Emily. (2023). Prior COVID-19 Infection Tied to Lasting Lung Abnormalities. JAMA. 329(11). 874–874. 1 indexed citations
20.
Barton, James C., Ronald T. Acton, Fitzroy W. Dawkins, et al.. (2005). Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study. Genetic Testing. 9(3). 231–241. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026